Review article: Diagnosis and management of mesenteric ischaemia with an emphasis on pharmacotherapy

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2005, Pages 201-215

  Kozuch, P L ^a   Brandt, L J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GASTRIC INHIBITORY POLYPEPTIDE; GENTAMICIN; GLUCAGON; GLYCERYL TRINITRATE; GLYCINE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 11; METRONIDAZOLE; OXYGEN; PAPAVERINE; PHENOXYBENZAMINE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN D2; SAUVAGINE; STREPTOKINASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TISSUE PLASMINOGEN ACTIVATOR; TOLAZOLINE; UNINDEXED DRUG; UROKINASE; UROTENSIN I; VASODILATOR AGENT; WARFARIN;

ABDOMINAL ANGIOGRAPHY; ABDOMINAL PAIN; ACUTE MESENTERIC ISCHEMIA; ACUTE MESENTERIC VENOUS THROMBOSIS; BLEEDING; CARDIOVASCULAR DISEASE; CELL DAMAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; HUMAN; HYPERCOAGULABILITY; HYPOTENSION; INTESTINE BLOOD FLOW; INTESTINE INFARCTION; MESENTERY DISEASE; MORBIDITY; MORTALITY; NON OCCLUSIVE MESENTERIC ISCHEMIA; NONHUMAN; NUTRIENT; PAIN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; REVIEW; RISK FACTOR; SPLANCHNIC BLOOD FLOW; STENT; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; TREATMENT INDICATION; VASOSPASM; VEIN THROMBOSIS; WEIGHT REDUCTION;

ANTIOXIDANTS; HUMANS; ISCHEMIA; MESENTERIC VASCULAR OCCLUSION; MESENTERIC VEINS; MESENTERY; THROMBOLYTIC THERAPY; THROMBOSIS; VASODILATOR AGENTS;

EID: 14044266310     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02269.x     Document Type: Review

References (77)

1. Brandt LJ, Boley SJ. Intestinal ischaemia. In: Feldman, M, Friedman, LS, Sleisenger, MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Philadelphia, PA, USA: WB Saunders, 2002: 2321-40.
2. Brandt LJ, Boley SJ. AGA technical review on intestinal ischaemia. Gastroenterology 2000; 118: 954-68.
3. Kornblith PL, Boley SJ, Whitehouse BS. Anatomy of the splanchnic circulation. Surg Clin North Am 1992; 72: 1-30.
4. Patel A, Kaleya RN, Sammartano RJ. Pathophysiology of mesenteric ischaemia. Surg Clin North Am 1992; 72: 31-41.
5. Lundgren O, Svanvik J, Mucosal hemodynamics in the small intestine of the cat during reduced perfusion pressure. Acta Phyiol Scand 1973; 88: 551-63.
6. Boley S, Brandt L, Veith F. Ischaemic disorders of the intestines. Curr Probl Surg 1978; 15: 1-85.
7. Zimmerman BJ, Granger DN. Reperfusion injury. Surg Clin North Am 1992; 72: 65-83.
8. Mitsudo S, Brandt LJ, Pathology of intestinal ischaemia. Surg Clin North Am 1992; 72: 43-63.
9. Gennaro M, Ascer E, Matano R, et al. Acute mesenteric ischaemia after cardiopulmonary bypass. Am J Surg 1993; 166: 2321-36.
10. Diamond SM, Emmett M, Henrich WL. Bowel infarction as a cause of death in dialysis patients. JAMA 1986; 256: 2545-7.
11. Osorio J, Farreras N, Ortiz De Zarate L, et al. Cocaine-induced mesenteric ischaemia. Dig Surg 2000; 17: 648-51.
12. Finucane PM, Arunachalam T, O'Dowd J, et al. Acute mesenteric infarction in elderly patients. J Am Geriatr Soc 1989; 37: 355-8.
13. Greenwald DA, Brandt LJ, Reinus JF. Ischaemic bowel disease in the elderly. Gastroenterol Clin North Am 2001; 30: 445-73.
14. Kirkpatrick IDC, Kroeker MA, Greenberg HM. Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischaemia: initial experience. Radiology 2003; 229: 91-8.
15. Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging 2002; 27: 488-506.
16. Burkart DJ, Johnson CD, Reading CC, et al. MR measurements of mesenteric venous flow: prospective evaluation in healthy volunteers and patients with suspected chronic mesenteric ischaemia. Radiology 1995; 194: 801-6.
17. Li KCP, Hopkins KL, Dalman RL, et al. Simultaneous measurement of flow in the superior mesenteric vein and artery with cine phase contrast MR imaging: value in diagnosis of chronic mesenteric ischaemia. Radiology 1995; 194: 327-30.
18. Smerud MJ, Johnson CD, Stephens DH. Diagnosis of bowel infarction: a comparison of plain films and CT scans in 23 cases. Am J Roentgenol 1990; 154: 99-103.
19. Taourel PG, Deneuville M, Pradel JA, et al. Acute mesenteric ischaemia: diagnosis with contrast enhanced CT. Radiology 1996; 199: 632-6.
20. Rhee RY, Gloviczki P, Medonca CT, et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994; 20: 688-97.
21. Kurland B, Brandt LJ, Delany HM. Diagnostic tests for intestinal ischaemia. Surg Clin North Am 1992; 72: 85-105.
22. Gearhart SL, Delaney CP, Senagore AJ, et al. Prospective assessment of the predictive value of α-glutathione S-transferase for intestinal ischaemia. Am Surg 2003; 69: 324-9.
23. Kanda T, Fuji H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996; 110: 339-43.
24. Guthmann F, Borchers T, Wolfrum C, et al. Plasma concentration of intestinal-and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002; 239: 227-34.
25. 5 Grum CM, Fiddian-Green RG, Pittenger GL, et al. Adequacy of tissue oxygenation in intact dog intestine. J Appl Physiol 1984; 56: 1065-9.
26. Taylor, DE. Revving the motor of multiple organ dysfunction syndrome: gut dysfunction in ARDS and multiorgan failure. Resp Care Clin North Am 1998; 4: 611-29.
27. 7 Boley SJ, Brandt LJ, Veith FJ, et al. A new provocative test for chronic mesenteric ischaemia. Am J Gastroenterol 1991; 86: 888-91.
28. Bjorck M, Hedberg B. Early detection of major complications after abdominal aortic surgery: predictive value of sigmoid colon and gastric intramucosal pH monitoring. Br J Surg 1994; 81: 25-30.
29. Kleinhaus S, Sammartano R, Boley SJ. Effects of laparoscopy on mesenteric blood flow. Arch Surg 1978; 113: 867-9.
30. Brandt LJ, Boley SJ, Sammartano R. Carbon dioxide and room air insufflation of the colon. Gastrointest Endosc 1986; 32: 324-9.
31. Seidel SA, Bradshaw LA, Ladipo JK, et al. Noninvasive detection of ischaemic bowel. J Vase Surg 1999; 30: 309-19.
32. Bennion RS, Wilson SE, Williams RA. Early portal anaerobic bacteremia in mesenteric ischaemia. Arch Surg 1984; 199: 151-5.
33. Jamieson WG, Pliagus G, Marchuk S, et al. Effect of antibiotic and fluid resuscitation upon survival time in experimental intestinal ischaemia. Surg Gynecol Obstet 1988; 167: 103-8.
34. Plonka AJ, Schentag JJ, Messinger S, et al. Effects of enteral and intravenous antimicrobial treatment on survival following intestinal ischaemia in rats. J Surg Res 1989; 46: 216-20.
35. Park WM, Gloviczki P, Cherry KJ, et al. Contemporary management of acute mesenteric ischaemia: factors associated with survival. J Vase Surg 2002; 35: 445-52.
36. Van Deinse WH, Zawacki JK, Phillips D. Treatment of acute mesenteric ischaemia by percutaneous transluminal angioplasty. Gastroenterology 1986; 91: 475-8.
37. Babior BM, Stossel TP. The clotting cascade and its regulation: congenital and acquired clotting factor disorders. In: Babior, BM, Stossel, TP, eds. Hematology: A Pathophysiological Approach, New York, NY, USA: Churchill Livingstone, 1994: 189-211.
38. Bell WR. Therapeutic agents - pharmacokinetics and pharmacodynamics. Rev Cardiovasc Med 2002; 2: s34-44.
39. Smithline AE, Brandt LJ. Drug therapies for mesenteric vascular disease. In: Frishman, WH, ed. Cardiovascular Pharmacotherapeutics, New York, NY, USA: McGraw-Hill, 1997: 1211-9.
40. Simo G, Echenagusia AJ, Camunez F, et al. Superior mesenteric arterial embolism: local fibrinolytic treatment with urokinase. Radiology 1997; 204: 775-9.
41. Sammartano RJ, Boley SJ, Kleinhaus S, Sprayragen S. Intraarterial papaverine HCl in acute superior mesenteric arterial occlusion. Gastroenterology 1981; 80: 1269 (Abstract).
42. Boley SJ, Sammartano RJ, Brandt LJ, et al. Intra-arterial vasodilators and thrombolytic agents in experimental superior mesenteric artery embolus. Gastroenterology 1982; 82: 1021.
43. Fondacaro JD, Walus KM, Schwaiger M, et al. Vasodilation of the normal and ischaemic canine mesenteric circulation. Gastroenterology 1981; 80: 1542-9.
44. Boley SJ, Sprayregan S, Siegelman SS, et al. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischaemia. Surgery 1977; 82: 848-55.
45. Bulkley GB, Womack WA, Downey JM, et al. Characterization of segmental collateral blood flow in the small intestine. Am J Physiol 1985; 249: 228-35.
46. Bulkley GB, Womack WA, Downey JM, et al. Collateral blood flow in segmental intestinal ischaemia: effects of vasoactive agents. Surgery 1986; 100: 157-66.
47. Meilahn JE, Morris JB, Ceppa EP, et al. Effect of prolonged selective intramesenteric arterial vasodilator therapy on intestinal viability after acute segmental mesenteric vascular occlusion. Ann Surg 2001; 234: 107-15.
48. Katzung BG. Pancreatic hormones and antidiabetic drugs. In: Katzung, BG, ed. Basic and Clinical Pharmacology, Stamford, CT: Appleton & Lange, 2002: 711-34.
49. Gangadharn SP, Wagner RJ, Cronenwett JL. Effect of intravenous glucagon on intestinal viability after segmental mesenteric ischaemia. J Vase Surg 1995; 21: 900-8.
50. Clark ET, Gewertz BL. Glucagon potentiates intestinal reperfusion injury. J Vasc Surg 1990; 11: 270-9.
51. Bassiouny HS. Nonocclusive mesenteric ischaemia. Surg Clin North Am 1997; 77: 319-26.
52. Siegelman SS, Sprayregen S, Boley SJ. Angiographic diagnosis of mesenteric arterial infarction. Radiology 1974; 122: 533.
53. Bailey RW, Bulkley GB, Hamilton SR, et al. Protection of the small intestine from nonocclusive mesenteric ischaemic injury due to cardiogenic shock. Am J Surg 1987; 153: 108-16.
54. Jakschik J, Jaeger U. Interventional therapy of nonocclusive mesenteric ischaemia with captopril: an experimental animal study. ROFO-Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden V 1996; 164: 502-6.
55. Schwaiger M, Fondacaro JD, Jacobson ED. Effects of glucagon, histamine, and perhexiline on the ischaemic canine mesenteric circulation. Gastroenterology 1979; 77: 730-5.
56. Kang H, Manasia A, Rajamani S, et al. Intravenous iloprost increases mesenteric blood flow in experimental acute nonocclusive mesenteric ischaemia. Crit Care Med 2002; 30: 2528-34.
57. MacCannell KL, Newton CA, Lederis K, et al. Use of selective mesenteric vasodilator peptides In experimental nonocclusive mesenteric ischaemia in the dog. Gastroenterology 1986; 90: 669-76.
58. MacCannell KL. Comparison of an intravenous selective mesenteric vasodilator with intrarterial papaverine in experimental nonocclusive mesenteric ischaemia. Gastroenterology 1986; 91: 79-83.
59. Kogire M, Inoue K, Sumi S, et al. Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs. Gastroenterology 1988; 95: 1636-40.
60. Brunaud L, Antunes L, Collinet-Adler S, et al. Acute mesenteric venous thrombosis: case for nonoperative management. J Vase Surg 2001; 34: 673-9.
61. Kasirajan K, O'Hara PJ, Gray BH, et al. Chronic mesenteric ischaemia: open surgery versus percutaneous angioplasty and stenting. J Vase Surg 2001; 33: 63-71.
62. Sharafuddin MJ, Olson CH, Sun S, et al. Endovascular treatment of celiac and mesenteric arteries stenosis: applications and results. J Vasc Surg 2003; 38: 692-8.
63. Kazez A, Demirbag M, Ustundag B, et al. The role of melatonin in prevention of intestinal ischaemia-reperfusion injury in rats. J Ped Surg 2000; 35: 1444-8.
64. Koltuksuz U, Ozen S, Uz E, et al. Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. J Ped Surg 1999; 34: 1458-62.
65. Ceran C, Sonmez K, Turkyllmaz Z, et al. Effect of bilirubin in ischaemia/reperfusion injury on rat small intestine. J Ped Surg 2001; 36: 1764-7.
66. Fink MD. Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med 2003; 31: S51-6.
67. Schmeling DJ, Caty MG, Oldham KT, et al. Cytoprotection by diclofenac sodium after intestinal ischaemia/reperfusion injury. J Ped Surg 1994; 29: 1044-8.
68. Ilhan H, Alatas O, Tokar B, et al. Effects of the anti-ICAM-1 monoclonal antibody, allopurinol and methylene blue on intestinal reperfusion injury. J Ped Surg 2003; 38: 1591-5.
69. Xia G, Martin AE, Besner GE. Heparin-binding EGF-like growth factor down-regulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischaemia/reperfusion injury. J Ped Surg 2003; 38: 434-9.
70. Kuenzler KA, Pearson PY, Schwartz MZ. Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischaemia-reperfusion. J Ped Surg 2002; 37: 1093-7.
71. Kuenzler KA, Arthur LG, Schwartz MZ. A possible mechanism for prevention of intestinal programmed cell death after ischaemia-reperfusion injury by hepatocyte growth factor pretreatment. J Ped Surg 2002; 37: 1696-9.
72. Khanna A, Rossman J, Caty MG, et al. Beneficial effects of intraluminal nitroglycerin in intestinal ischaemia-reperfusion injury in rats. J Surg Res 2003; 114: 15-24.
73. Jacob T, Ascher E, Hingorani A, et al. Glycine prevents the induction of apoptosis attributed to mesenteric ischaemia/reperfusion injury in a rat model. Surgery 2003; 134: 1043-49.
74. Prasad R, Alavi K, Schwartz MZ. Glucagon-like peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischaemia-reperfusion injury. J Ped Surg 2000; 35: 1537-9.
75. Kuenzler KA, Pearson PY, Schwartz MZ. Interleukin-11 enhances intestinal absorptive function after ischaemia-reperfusion injury. J Ped Surg 2002; 37: 457-9.
76. Bounous G. Pancreatic proteases and oxygen-derived free radicals in acute ischaemic enteropathy. Surgery 1986; 99: 92-4.
77. Oldham KT, Guice KS, Gore D, et al. Treatment of intestinal ischaemia with oxygenated intraluminal perfluorocarbon. Am J Surg 1987; 153: 291-4.